NO901241D0 - Fremgangsmaate ved fremstilling av pyrrolidinderivater. - Google Patents
Fremgangsmaate ved fremstilling av pyrrolidinderivater.Info
- Publication number
- NO901241D0 NO901241D0 NO901241A NO901241A NO901241D0 NO 901241 D0 NO901241 D0 NO 901241D0 NO 901241 A NO901241 A NO 901241A NO 901241 A NO901241 A NO 901241A NO 901241 D0 NO901241 D0 NO 901241D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolide
- ingredients
- procedure
- preparation
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898906166A GB8906166D0 (en) | 1989-03-17 | 1989-03-17 | Therapeutic agents |
Publications (4)
Publication Number | Publication Date |
---|---|
NO901241D0 true NO901241D0 (no) | 1990-03-16 |
NO901241L NO901241L (no) | 1990-09-18 |
NO176316B NO176316B (no) | 1994-12-05 |
NO176316C NO176316C (no) | 1995-03-15 |
Family
ID=10653525
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO901241A NO176316C (no) | 1989-03-17 | 1990-03-16 | Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrrolidinderivater, samt mellomprodukt for framstilling av disse forbindelsene |
NO2005008C NO2005008I2 (no) | 1989-03-17 | 2005-04-01 | Emselex-darifenacin kjemisk navn: 3-(S)-(-)-(1-karbamoyl-1,1-difenylmetyl)-1-Ä2-(2,3-dihydrobenzofuran-5-yl)etylÜpyrrolidin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2005008C NO2005008I2 (no) | 1989-03-17 | 2005-04-01 | Emselex-darifenacin kjemisk navn: 3-(S)-(-)-(1-karbamoyl-1,1-difenylmetyl)-1-Ä2-(2,3-dihydrobenzofuran-5-yl)etylÜpyrrolidin |
Country Status (37)
Country | Link |
---|---|
US (1) | US5096890B1 (no) |
EP (1) | EP0388054B1 (no) |
JP (2) | JPH0764809B2 (no) |
KR (2) | KR920008166B1 (no) |
CN (1) | CN1023007C (no) |
AT (1) | ATE96783T1 (no) |
AU (1) | AU614224B2 (no) |
BA (1) | BA98300A (no) |
CA (1) | CA2012295C (no) |
CL (1) | CL2003002756A1 (no) |
CY (2) | CY1812A (no) |
CZ (1) | CZ280053B6 (no) |
DD (1) | DD292911A5 (no) |
DE (2) | DE69004302T2 (no) |
DK (1) | DK0388054T3 (no) |
EG (1) | EG18951A (no) |
ES (1) | ES2060020T3 (no) |
FI (1) | FI95573C (no) |
GB (1) | GB8906166D0 (no) |
HK (1) | HK130294A (no) |
HU (2) | HU217433B (no) |
IE (1) | IE62515B1 (no) |
IL (1) | IL93694A (no) |
LU (1) | LU91161I2 (no) |
MX (1) | MX9319890A (no) |
MY (1) | MY105527A (no) |
NL (1) | NL300191I2 (no) |
NO (2) | NO176316C (no) |
NZ (1) | NZ232958A (no) |
PL (1) | PL164136B1 (no) |
PT (1) | PT93443B (no) |
RU (2) | RU1833374C (no) |
SG (1) | SG143394G (no) |
SK (1) | SK129590A3 (no) |
UA (1) | UA18263A (no) |
YU (1) | YU47587B (no) |
ZA (1) | ZA901982B (no) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932594A (en) * | 1988-11-01 | 1999-08-03 | Pfizer, Inc. | Muscarinic receptor antagonists |
GB8825505D0 (en) * | 1988-11-01 | 1988-12-07 | Pfizer Ltd | Therapeutic agents |
GB8928042D0 (en) * | 1989-12-12 | 1990-02-14 | Pfizer Ltd | Muscarinic receptor antagonists |
US5607950A (en) * | 1990-01-06 | 1997-03-04 | Pfizer Inc. | Muscarinic receptor antagonists |
US5486527A (en) * | 1990-01-06 | 1996-01-23 | Pfizer Inc. | Anticholinergic agents |
CA2134077C (en) * | 1992-04-23 | 2002-05-21 | Thaddeus R. Nieduzak | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
US6017931A (en) * | 1994-03-01 | 2000-01-25 | Fmc Corporation | Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
US5639763A (en) * | 1994-03-01 | 1997-06-17 | Fmc Corporation | Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines |
AU704085B2 (en) * | 1994-07-27 | 1999-04-15 | Vanderbilt University | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US5656661A (en) * | 1994-07-27 | 1997-08-12 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
US5672620A (en) * | 1996-02-01 | 1997-09-30 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US5684031A (en) * | 1996-02-01 | 1997-11-04 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
CN1104239C (zh) * | 1996-12-02 | 2003-04-02 | 杏林制药株式会社 | 新颖的n-取代的吡咯烷衍生物及其制备方法 |
US6131129A (en) * | 1997-07-30 | 2000-10-10 | Sony Corporation Of Japan | Computer system within an AV/C based media changer subunit providing a standarized command set |
US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
IL141235A (en) * | 2000-02-09 | 2012-04-30 | Novartis Int Pharm Ltd | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia |
US6653339B2 (en) | 2001-08-15 | 2003-11-25 | Pfizer Inc. | Method of treating irritable bowel syndrome |
MXPA04003865A (es) * | 2001-10-26 | 2004-07-08 | Upjohn Co | Compuestos de amonio cuaternario y sus usos como agentes antimuscarinicos. |
SE0103668D0 (sv) * | 2001-11-02 | 2001-11-02 | Astrazeneca Ab | Method for the treatment of overactive blader |
JP2005511582A (ja) * | 2001-11-05 | 2005-04-28 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | 抗ムスカリン・エアゾール |
GB0129962D0 (en) * | 2001-12-14 | 2002-02-06 | Pfizer Ltd | Method of treatment |
GB0207104D0 (en) | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
BR0215801A (pt) | 2002-07-08 | 2005-05-10 | Ranbaxy Lab Ltd | Derivados de 3,6-dissubstituìdos azabiciclo [3.1.0] hexano úteis como antagonistas de receptores muscarìnicos |
EP1546098B1 (en) | 2002-07-31 | 2008-05-28 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
US7410993B2 (en) | 2002-08-09 | 2008-08-12 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists |
WO2004018422A1 (en) | 2002-08-23 | 2004-03-04 | Ranbaxy Laboratories Limited | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists |
TW200412945A (en) * | 2002-10-25 | 2004-08-01 | Upjohn Co | Quaternary ammonium compounds |
TW200800953A (en) | 2002-10-30 | 2008-01-01 | Theravance Inc | Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine |
EP1572648B1 (en) | 2002-12-10 | 2008-07-09 | Ranbaxy Laboratories, Ltd. | 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists |
WO2004056811A1 (en) | 2002-12-23 | 2004-07-08 | Ranbaxy Laboratories Limited | Flavaxate derivatives as muscarinic receptor antagonists |
AU2002347552A1 (en) | 2002-12-23 | 2004-07-14 | Ranbaxy Laboratories Limited | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
US7488748B2 (en) | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
JP4767842B2 (ja) | 2003-04-01 | 2011-09-07 | セラヴァンス, インコーポレーテッド | β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
US7517905B2 (en) | 2003-04-09 | 2009-04-14 | Ranbaxy Laboratories Limited | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
EP1615887A1 (en) | 2003-04-10 | 2006-01-18 | Ranbaxy Laboratories, Ltd. | Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
JP2006514978A (ja) | 2003-04-10 | 2006-05-18 | ランバクシー ラボラトリーズ リミテッド | ムスカリン受容体アンタゴニストである置換アザビシクロヘキサン誘導体 |
EA009387B1 (ru) | 2003-04-11 | 2007-12-28 | Рэнбакси Лабораториз Лимитед | Азабициклические производные в качестве антагонистов мускаринового рецептора |
WO2004091597A2 (en) * | 2003-04-15 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Method of treating irritable bowel syndrome (ibs) |
WO2004091607A1 (en) * | 2003-04-15 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Quaternary ammonium compounds and their use as antimuscarinic agents |
WO2004091596A2 (en) * | 2003-04-18 | 2004-10-28 | Pharmacia & Upjohn Company Llc | Combination therapies for chronic obstructive pulmonary disease (copd) |
TW200510298A (en) | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
JP2007524641A (ja) | 2003-07-11 | 2007-08-30 | セラヴァンス, インコーポレーテッド | 置換4−アミノ−1−ベンジルピペリジン化合物 |
WO2005087763A1 (en) * | 2004-03-11 | 2005-09-22 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
EP1725525A1 (en) * | 2004-03-11 | 2006-11-29 | Theravance, Inc. | Diphenylmethyl compounds useful as muscarinic receptor antagonists |
WO2005092341A1 (en) * | 2004-03-22 | 2005-10-06 | Ranbaxy Laboratories Limited | Combination therapy for lower urinary tract symptoms |
BRPI0617674A2 (pt) | 2005-10-19 | 2011-08-02 | Ranbaxy Lab Ltd | composições farmacêuticas e seus usos |
CA2630478A1 (en) * | 2005-12-27 | 2007-07-05 | Teva Pharmaceutical Industries, Ltd | Processes for preparing darifenacin hydrobromide |
AR062676A1 (es) | 2006-09-07 | 2008-11-26 | Medichem Sa | Procedimiento mejorado para preparar compuestos de pirrolidina 1,3-disustituidas |
WO2008076269A2 (en) * | 2006-12-13 | 2008-06-26 | Gilead Sciences, Inc. | MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS |
EP2109601A2 (en) * | 2007-01-05 | 2009-10-21 | Dr. Reddy's Laboratories Ltd. | Preparation of darifenacin and its salts |
BRPI0807615A8 (pt) * | 2007-02-23 | 2017-12-05 | Theravance Inc | Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico |
WO2008126106A2 (en) * | 2007-04-16 | 2008-10-23 | Manne Satyanarayana Reddy | Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts |
WO2009007853A2 (en) * | 2007-06-08 | 2009-01-15 | Actavis Group Ptc Ehf | Novel polymorphs of darifenacin free base and its hydrobromide salt |
AR067001A1 (es) * | 2007-06-15 | 2009-09-30 | Medichem Sa | Un metodo para determinar la pureza enantiomerica de darifenacina e intermedios |
US20090005431A1 (en) * | 2007-06-30 | 2009-01-01 | Auspex Pharmaceuticals, Inc. | Substituted pyrrolidines |
WO2009010846A2 (en) * | 2007-07-13 | 2009-01-22 | Medichem, S.A. | Amorphous form of darifenacin hydrobromide and processes for the preparation thereof |
CZ300895B6 (cs) | 2008-01-28 | 2009-09-02 | Zentiva, A. S. | Zpusob prípravy Darifenacinu |
WO2009125430A2 (en) * | 2008-03-17 | 2009-10-15 | Matrix Laboratoires Limited | Improved process for producing darifenacin |
EP2261205A4 (en) * | 2008-04-02 | 2012-06-06 | Kaneka Corp | PROCESS FOR PRODUCING (S) -3- (1-CYANO-1,1-DIPHENYLMETHYL) -PYRROLIDINE |
US20110144354A1 (en) * | 2008-09-22 | 2011-06-16 | Watson Pharma Private Limited | Process for Preparation of Darifenacin and Intermediates Used in the Process |
EP2236509A1 (en) | 2009-04-01 | 2010-10-06 | Ragactives, S.L. | Method for obtaining 1,3-difunctionalized pyrrolidine derivatives |
KR20120025519A (ko) | 2009-05-15 | 2012-03-15 | 레드엑스 파마 리미티드 | 산화환원 약물 유도체 |
WO2011070419A1 (en) | 2009-12-10 | 2011-06-16 | Aurobindo Pharma Limited | An improved process for the preparation of darifenacin hydrobromide |
CA2796877A1 (en) | 2010-04-30 | 2011-11-03 | Merck Sharp & Dohme Corp. | Novel beta 3 adrenergic receptor agonists |
CN101857581A (zh) * | 2010-06-22 | 2010-10-13 | 浙江美诺华药物化学有限公司 | 一种制备达非那新中间体5-(2-溴乙基)-2,3-二氢-1-苯并呋喃的方法 |
WO2011161504A1 (en) | 2010-06-23 | 2011-12-29 | Micro Labs Limited | Extended release formulations containing darifenacin or pharmaceutically acceptable salts thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1057145A (en) * | 1963-08-16 | 1967-02-01 | Bellon Labor Sa Roger | Phenylcyclohexylacetonitrile derivatives |
US4002766A (en) * | 1974-12-26 | 1977-01-11 | A. H. Robins Company, Incorporated | Antiarrhythmia methods |
US4242261A (en) * | 1979-07-19 | 1980-12-30 | A. H. Robins Company, Inc. | Production of methylene-cycloamines |
US4594343A (en) * | 1984-10-19 | 1986-06-10 | Shanklin Jr James R | 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles |
IL76583A (en) * | 1984-10-19 | 1988-08-31 | Robins Co Inc A H | 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them |
EP0235463A3 (en) * | 1985-12-20 | 1990-01-17 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents |
IN163948B (no) * | 1986-01-17 | 1988-12-10 | Robins Co Inc A H |
-
1989
- 1989-03-17 GB GB898906166A patent/GB8906166D0/en active Pending
-
1990
- 1990-03-02 ES ES90302269T patent/ES2060020T3/es not_active Expired - Lifetime
- 1990-03-02 EP EP90302269A patent/EP0388054B1/en not_active Expired - Lifetime
- 1990-03-02 DE DE90302269T patent/DE69004302T2/de not_active Expired - Lifetime
- 1990-03-02 DE DE200512000022 patent/DE122005000022I2/de active Active
- 1990-03-02 AT AT90302269T patent/ATE96783T1/de active
- 1990-03-02 DK DK90302269.7T patent/DK0388054T3/da active
- 1990-03-09 IL IL9369490A patent/IL93694A/en not_active IP Right Cessation
- 1990-03-13 US US07493068 patent/US5096890B1/en not_active Expired - Lifetime
- 1990-03-14 MX MX1989090A patent/MX9319890A/es unknown
- 1990-03-14 HU HU580/90A patent/HU217433B/hu unknown
- 1990-03-15 CA CA002012295A patent/CA2012295C/en not_active Expired - Lifetime
- 1990-03-15 JP JP2065521A patent/JPH0764809B2/ja not_active Expired - Lifetime
- 1990-03-15 KR KR1019900003453A patent/KR920008166B1/ko not_active IP Right Cessation
- 1990-03-15 PT PT93443A patent/PT93443B/pt not_active IP Right Cessation
- 1990-03-15 ZA ZA901982A patent/ZA901982B/xx unknown
- 1990-03-15 EG EG17090A patent/EG18951A/xx active
- 1990-03-16 NZ NZ232958A patent/NZ232958A/en unknown
- 1990-03-16 DD DD90338829A patent/DD292911A5/de not_active IP Right Cessation
- 1990-03-16 YU YU52790A patent/YU47587B/sh unknown
- 1990-03-16 UA UA4743599A patent/UA18263A/uk unknown
- 1990-03-16 MY MYPI90000416A patent/MY105527A/en unknown
- 1990-03-16 IE IE95590A patent/IE62515B1/en not_active IP Right Cessation
- 1990-03-16 SK SK1295-90A patent/SK129590A3/sk not_active IP Right Cessation
- 1990-03-16 FI FI901333A patent/FI95573C/fi active Protection Beyond IP Right Term
- 1990-03-16 AU AU51402/90A patent/AU614224B2/en not_active Expired
- 1990-03-16 NO NO901241A patent/NO176316C/no not_active IP Right Cessation
- 1990-03-16 CZ CS901295A patent/CZ280053B6/cs not_active IP Right Cessation
- 1990-03-16 PL PL90284342A patent/PL164136B1/pl unknown
- 1990-03-16 RU SU904743599A patent/RU1833374C/ru active
- 1990-03-17 CN CN90101543A patent/CN1023007C/zh not_active Expired - Lifetime
-
1991
- 1991-03-13 RU SU914894696A patent/RU2015965C1/ru active
-
1992
- 1992-08-12 KR KR1019920014485A patent/KR960015142B1/ko not_active IP Right Cessation
-
1994
- 1994-09-26 JP JP6229807A patent/JPH07149640A/ja active Pending
- 1994-10-03 SG SG143394A patent/SG143394G/en unknown
- 1994-11-24 HK HK130294A patent/HK130294A/xx not_active IP Right Cessation
-
1995
- 1995-06-28 HU HU95P/P00505P patent/HU211640A9/hu active Protection Beyond IP Right Term
- 1995-10-20 CY CY181295A patent/CY1812A/xx unknown
-
1998
- 1998-03-30 BA BA980300A patent/BA98300A/bs unknown
-
2003
- 2003-12-26 CL CL200302756A patent/CL2003002756A1/es unknown
-
2005
- 2005-04-01 NO NO2005008C patent/NO2005008I2/no unknown
- 2005-04-04 CY CY2005005C patent/CY2005005I1/el unknown
- 2005-04-08 NL NL300191C patent/NL300191I2/nl unknown
- 2005-04-11 LU LU91161C patent/LU91161I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO901241D0 (no) | Fremgangsmaate ved fremstilling av pyrrolidinderivater. | |
NO885655L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-methylpyrrolidin- og fucitolderivater. | |
DK0508988T3 (da) | Muscarinreceptor-antagonister | |
FI97468B (fi) | Menetelmä terapeuttisesti aktiivisten piperidiinijohdannaisten valmistamiseksi | |
DE69006745D1 (de) | Muscarin-rezeptor-antagonisten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: EMSELEX (7,5 MG DEPOTTABLETT MED 7, 14, 28, 49, 56 OG 98 TABLETTER I BLISTERPAKNING OG 15 MG DEPOTTABLETT MED 7, 14, 28, 49, 56 OG 98 TABLETTER I BLISTERPAKNING); NAT. REG. NO/DATE: 04/294/1-12 20041022 Spc suppl protection certif: 2005008 Filing date: 20050401 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: EMSELEX (7,5 MG DEPOTTABLETT MED 7, 14, 28, 49, 56 OG 98 TABLETTER I BLISTERPAKNING OG 15 MG DEPOTTABLETT MED 7, 14, 28, 49, 56 OG 98 TABLETTER I BLISTERPAKNING); NAT. REG. NO/DATE: 04/294/1-12 20041022 Spc suppl protection certif: 2005008 Filing date: 20050401 Extension date: 20150316 |
|
MK1K | Patent expired | ||
SPCX | Expiry of an spc |
Spc suppl protection certif: 2005008 Effective date: 20150316 |